Kimberly-Clark has defined the organizational structure for the combined entity resulting from its planned acquisition of Kenvue and has appointed its core executive leadership team. The acquisition is anticipated to be finalized later this year.
The merged company will encompass a portfolio of consumer brands, including Kleenex tissues and Huggies diapers, as well as over-the-counter products such as Tylenol and Listerine. It will operate through four major geographic business segments.
The North America segment is projected to be the largest business unit, with estimated annual sales of approximately $18 billion. The other three segments—Asia-Pacific Key Markets, Europe, Middle East & Africa, and Enterprise Markets—are each expected to generate annual sales between $4 billion and $5 billion.
Kimberly-Clark's Chief Executive Officer, Mike Hsu, will lead the newly combined company.
Executives reporting directly to Mike Hsu include:
- Russ Torres: Group President and Chief Operating Officer - Nelson Urdaneta: Chief Financial Officer - Stacy Wylie Panayiotou: Chief Human Resources Officer - Jeff Melucci: Chief Strategy, Business Development, and Administration Officer
Regional leaders appointed include:
- John Carmichael: President, North America - Katie Chan: President, Asia-Pacific Key Markets - Carlton Lawson: President, Europe, Middle East, and Africa
Mike Hsu stated, "Our structure is designed to align the team around accountability, agility, and execution. Regional markets will manage their businesses end-to-end, while functional teams will rapidly deploy core capabilities to empower the markets to win."
Kimberly-Clark agreed to acquire Kenvue for over $40 billion last November. The transaction received shareholder approval at the end of January. The company indicated that, pending regulatory approvals and the satisfaction of customary closing conditions, the deal remains on track for completion in the second half of 2026.
Comments